Patents by Inventor Keunchil Park

Keunchil Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10004694
    Abstract: Provided are a poorly water-soluble drug delivery system, a method of preparing the same, a method of delivering a poorly water-soluble drug using the same, and a pharmaceutical composition including the same as an effective component, and more particularly, a poorly water-soluble drug delivery system aiming cancer cell specific targeting, which may variously control the kind of a cancer cell targeting material capable of specifically reacting to an antigen overexpressed in a cancer cell, thereby binding to the surface of the poorly water-soluble drug delivery system, and variously control the kind of a poorly water-soluble drug encapsulated therein depending on the kind of cancer and a therapeutic purpose, thereby being effectively applicable to a cancer treatment method.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: June 26, 2018
    Assignee: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Keunchil Park, Jin-Ho Kim, Youngwook Kim, Ki Hyun Bae
  • Patent number: 9869668
    Abstract: Provided is a method for evaluating efficacy of, or resistance to, a c-Met targeting agent including measuring a level of a PDGF protein and/or a PDGF coding gene.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: January 16, 2018
    Assignees: SAMSUNG ELECTRONICS CO., LTD., SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
    Inventors: Jae Hyun Choi, Kyung Ah Kim, Youngwook Kim, Keunchil Park
  • Patent number: 9572878
    Abstract: A method of combination therapy for prevention and/or treatment of c-Met- and/or EGFR-induced diseases including co-administering a pharmaceutically effective amount of an EGFR antagonist and a pharmaceutically effective amount of an anti-c-Met antibody to a subject in need thereof is provided.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: February 21, 2017
    Assignees: SAMSUNG ELECTRONICS CO., LTD., SAMSUNG LIFE WELFARE FOUNDATION
    Inventors: Saet Byoul Lee, Jae Hyun Choi, Kyung Ah Kim, Ji Min Lee, Yun Ju Jeong, Keunchil Park, Youngwook Kim, Yumi Lee
  • Publication number: 20160061815
    Abstract: Provided is a method for evaluating efficacy of, or resistance to, a c-Met targeting agent including measuring a level of a PDGF protein and/or a PDGF coding gene.
    Type: Application
    Filed: August 26, 2015
    Publication date: March 3, 2016
    Inventors: Jae Hyun Choi, Kyung Ah Kim, Youngwook Kim, Keunchil Park
  • Publication number: 20150231087
    Abstract: Provided are a poorly water-soluble drug delivery system, a method of preparing the same, a method of delivering a poorly water-soluble drug using the same, and a pharmaceutical composition including the same as an effective component, and more particularly, a poorly water-soluble drug delivery system aiming cancer cell specific targeting, which may variously control the kind of a cancer cell targeting material capable of specifically reacting to an antigen overexpressed in a cancer cell, thereby binding to the surface of the poorly water-soluble drug delivery system, and variously control the kind of a poorly water-soluble drug encapsulated therein depending on the kind of cancer and a therapeutic purpose, thereby being effectively applicable to a cancer treatment method.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 20, 2015
    Inventors: Keunchil Park, Jin-Ho Kim, Youngwook Kim, Ki Hyun Bae